Fundraising FoxSamos Investments — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Axiom Therapeutics runs a drug discovery platform for covalent inhibitors, applying machine learning to speed up physics-based simulations.
BiotechLondon, GB
Ryan Geiser(CEO)inChris Haggard(CTO)inSofia Dahoune(Director)Ryan Geiser, PhD(Founder)in
Co-investorsCreative Destruction Lab (CDL)Entrepreneur FirstGaingelsLunar VenturesPlug and Play VenturesTranspose Platform Management+2 more
__Twitter.png)
Electric Twin builds synthetic audiences—large-scale simulations of real people generated from a client's customer data and validated against real-world benchmarks—that businesses query directly to get research answers in seconds.
AI & Machine LearningMarketing TechSaaS
Ben Warner(Founder)in
Co-investorsGMG VenturesLocalGlobeMercuri.vcAtomico
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.